Opigolix
id:
opigolix-295-12504244
title:
Opigolix
text:
Opigolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist which was under development by Astellas Pharma for the treatment of endometriosis and rheumatoid arthritis. It was also under investigation for the treatment of prostate cancer. It reached phase II clinical trials for both endometriosis and rheumatoid arthritis prior to the discontinuation of its development in April 2018.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Opigolix
date created:
date modified:
2022-07-14T01:42:01Z
main entity:
{"identifier":"Q48845420","url":"https://www.wikidata.org/entity/Q48845420"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/7e/Opigolix.svg","width":512,"height":284}
fields total:
13
integrity:
15